Patient NAME : Ms MAMTA DEVI

DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report

Patient ID / UHID : 11796886/RCL11054341 Barcode NO : HR472995
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 01:56 PM.
Test Description Value(s) Unit(s) Reference Range

Fit India Full Body Checkup With Vitamin Screening with Free HsCRP
Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 12.3 g/dL 12.0-15.0
colorimetric
RBC Count 4.7 10^6/µl 3.8 - 4.8
Electrical impedance
PCV 38.4 % 36 - 46
Calculated
MCV 81.9 fl 83 - 101
Calculated
MCH 26.2 pg 27 - 32
Calculated
MCHC 32 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 12.9 % 11.6 - 14.0
Calculated
RDW-SD * 38.4 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 5.8 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 57 % 40-80
Lymphocytes 37 % 20-40
Monocytes 4 % 2-10
Eosinophils 2 % 1-6
Basophils 0 % <2
Absolute Leukocyte Counts
Calculated
Neutrophils. 3.31 10^3/µl 2-7
Lymphocytes. 2.15 10^3/µl 1-3
Monocytes. 0.23 10^3/µl 0.2 - 1.0
Eosinophils. 0.12 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 156 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 14.8 fL 9.3 - 12.1
Calculated
PCT * 0.2 % 0.17 - 0.32
Calculated
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 1 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : HR472995
Referred BY : Self Sample Type : Whole blood EDTA
Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 01:56 PM.
Test Description Value(s) Unit(s) Reference Range
PDW * 25 fL 8.3 - 25.0
Calculated
P-LCR * 58.6 % 18 - 50
Calculated
P-LCC * 64 10^9/L 44 - 140
Calculated
Mentzer Index * 17.43 % > 13
Calculated

PLATELET COUNT MANUALLY RECHECKED.

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 2 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : HR472995
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:31 PM.
Test Description Value(s) Unit(s) Reference Range

HbA1C (Glycosylated Haemoglobin)

Glycosylated Hemoglobin (HbA1c) 4.8 % < 5.7

HPLC
Estimated Average Glucose * 91.06 mg/dl Refer Table Below
Calculated

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %
may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as
compared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 3 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : ZH830700
Referred BY : Self Sample Type : FLUORIDE F
....

Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:31 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting

Glucose Fasting 78.7 mg/dL 70 - 100

Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels (hyperglycemia)
may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders. Decreased glucose
levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 4 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : ZH830701
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:32 PM.
Test Description Value(s) Unit(s) Reference Range

Liver Function Test (LFT)

Bilirubin Total 0.4 mg/dL 0.2 - 1.2

Photometric
Bilirubin Direct * 0.2 mg/dL 0.0 - 0.5
Diazo Reaction
Bilirubin Indirect * 0.2 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 45.3 U/L 5 - 34
IFCC without P5P
SGPT/ALT 57.6 U/L 0 to 55
IFCC without P5P
SGOT/SGPT Ratio * 0.79 - -
Alkaline Phosphatase 90.1 U/L 40 - 150
IFCC
Total Protein 7.7 g/dL 6.4 - 8.3
Biuret
Albumin 4.8 gm/dL 3.8 - 5.0
BCG
Globulin * 2.9 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.66 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 11.2 U/L 9 - 36
Photometric

Interpretation:
The liver filters blood, metabolizes nutrients, detoxifies harmful substances, and produces blood clotting proteins. Liver cells contain
enzymes that facilitate these functions. When cells are damaged, enzymes leak into the blood, detectable through blood tests.

Key enzymes tested:

1. AST (SGOT): may indicate tissue injury / damage in muscles or liver.

2. ALT (SGPT): Primarily in the liver. Elevated ALT and AST suggest liver damage.
3. Alkaline Phosphatase & GGT: Linked to bile production and flow. Elevated levels may indicate bile flow issues related to the liver,
gallbladder, or bile ducts.

Blood proteins, albumin and globulin, are essential for growth, development, and health.

1. Low protein: May indicate bleeding, liver disorders, malnutrition, or agammaglobulinemia.

2. High protein (Hyperproteinemia): Often due to dehydration or increased protein production.
3. Low albumin: Caused by poor diet, kidney, or liver disease.
4. High albumin: Usually due to severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 5 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : ZH830701
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:32 PM.
Test Description Value(s) Unit(s) Reference Range

Kidney Function Test (KFT)

Blood Urea 22 mg/dL 19 - 44.1

Urease
Bun * 10.28 mg/dL 7.0 - 18.7
Urease
Creatinine 0.5 mg/dL 0.57 - 1.11
Photometric
eGFR (CKD-EPI) 127.70 ml/min/1.73 sq m Normal Or High: >= 90

Mild Or Decrease: 60-89

Mild To Moderate Decrease:

45-59

Mild To Severe Decrease:

30-44

Severe Decrease: 15-29

Kidney Failure: < 15

Bun/Creatinine Ratio * 20.56 12 - 20
Calculated
Urea / Creatinine Ratio * 44 25.68- 42.8
Calculated
Uric Acid 3.5 mg/dL 2.6 - 6.0
Uricase
Calcium Serum 8.4 mg/dL 8.4 - 10.2
Arsenazo III
Phosphorus 3.6 mg/dL 2.3 - 4.7
Photometric
Sodium 132.8 mmol/L 136 - 145
Potentiometric
Potassium 3.9 mmol/L 3.5 - 5.1
Potentiometric
Chloride 100.7 mmol/L 98 - 107
Potentiometric

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual (chronic)
declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may indicate a problem with
your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful urination,swelling in the hands and feet due
to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these symptoms suggest that your
kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes are present in the human body and the balancing act of the
electrolytes in our bodies is essential for normal function of our cells and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or
parathyroid disease. The test may also be done to monitor progress and treatment of these diseases.
"eGFR test is applicable for patients aged 18 years or more."

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 6 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : ZH830701
Referred BY : Self Sample Type : Serum
Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:32 PM.
Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 7 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : ZH830701
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:32 PM.
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 158 mg/dL <200

Enzymatic - Cholesterol Oxidase
Triglycerides 123 mg/dL <150
Colorimetric - Lip/Glycerol Kinase
HDL Cholesterol 43.4 mg/dL >40
Accelerator Selective Detergent
Non HDL Cholesterol * 114.6 mg/dL <130
Calculated
LDL Cholesterol * 90 mg/dL <100
Calculated
V.L.D.L Cholesterol * 24.6 mg/dL < 30
Calculated
Chol/HDL Ratio * 3.64 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.48 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 2.07 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 8 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : ZH830701
Referred BY : Self Sample Type : Serum
Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:32 PM.
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors

Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors

1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 9 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : ZH830701
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:32 PM.
Test Description Value(s) Unit(s) Reference Range

High Sensitivity C-Reactive Protein (Hs-CRP)

HIGHLY SENSITIVE C-REACTIVE PROTEIN (hs- 1.1 mg/L < 1.00

CRP)
immunoturbidimetric

Interpretation:

Cardio CRP In mg/L Cardiovascular Risk

<1 Low
1-3 Average
3-10 High
Persistent elevation may represent
>10
Non cardiovascular inflammation

Note: To assess vascular risk, it is recommended to test hsCRP levels 2 or more weeks apart and calculate the average

Comments:
High sensitivity C Reactive Protein (hsCRP) significantly improves cardiovascular risk assessment as it is a strongest predictor of future coronary events. It
reveals the risk of future Myocardial infarction and Stroke among healthy men and women, independent of traditional risk factors. It identifies patients at risk of
first Myocardial infarction even with low to moderate lipid levels. The risk of recurrent cardiovascular events also correlates well with hsCRP levels. It is a
powerful independent risk determinant in the prediction of incident Diabetes.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 10 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : YB873124
Referred BY : Self Sample Type : Spot Urine
....

Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:19 PM.
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume * 20 mL -
Colour * Pale yellow - Pale yellow
Transparency * Slightly Hazy - Clear
Deposit * Present - Absent
Chemical Examination
Reaction (pH) 7.0 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.010 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Oxidase / Peroxidase
Urine Protein (Albumin) Negative - Negative
Acid / Base Colour Excahnge
Urine Ketones (Acetone) Negative - Negative
Legals Test
Blood Negative - Negative
Peroxidase Hemoglobin
Leucocyte esterase Negative - Negative
Enzymatic Reaction
Bilirubin Urine Negative - Negative
Coupling Reaction
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) * 1-2 /hpf 0-5
Epithelial Cells * 2-4 /hpf 0-4
Red blood Cells * Absent /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria Absent - Absent
Protozoa * Absent - Absent
Interpretation:
URINALYSIS- Routine urine analysis assists in screening and diagnosis of various metabolic, urological, kidney and liver disorders.

Protein: Elevated proteins can be an early sign of kidney disease. Urinary protein excretion can also be temporarily elevated by strenuous
exercise, orthostatic proteinuria, dehydration, urinary tract infections and acute illness with fever

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 11 of 12
 Patient NAME : Ms MAMTA DEVI
DOB/Age/Gender : 32 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11796886/RCL11054341 Barcode NO : YB873124
Referred BY : Self Sample Type : Spot Urine
Sample Collected : Mar 22, 2025, 09:30 AM Report Date : Mar 22, 2025, 02:19 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose: Uncontrolled diabetes mellitus can lead to presence of glucose in urine. Other causes include pregnancy, hormonal disturbances,
liver disease and certain medications.

Ketones: Uncontrolled diabetes mellitus can lead to presence of ketones in urine. Ketones can also be seen in starvation, frequent vomiting,
pregnancy and strenuous exercise.

Blood: Occult blood can occur in urine as intact erythrocytes or haemoglobin, which can occur in various urological, nephrological and bleeding
disorders.

Leukocytes: An increase in leukocytes is an indication of inflammation in urinary tract or kidneys. Most common cause is bacterial urinary tract
infection.

Nitrite: Many bacteria give positive results when their number is high. Nitrite concentration during infection increases with length of time the
urine specimen is retained in bladder prior to collection.

pH: The kidneys play an important role in maintaining acid base balance of the body. Conditions of the body producing acidosis/ alkalosis or
ingestion of certain type of food can affect the pH of urine.

Specific gravity: Specific gravity gives an indication of how concentrated the urine is. Increased specific gravity is seen in conditions like
dehydration, glycosuria and proteinuria while decreased specific gravity is seen in excessive fluid intake, renal failure and diabetes insipidus.

Bilirubin: In certain liver diseases such as biliary obstruction or hepatitis, bilirubin gets excreted in urine.

Urobilinogen: Positive results are seen in liver diseases like hepatitis and cirrhosis and in cases of haemolytic anaemia.

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 12 of 12